Editorial: Overcoming drug relapse and therapy resistance in NSCLC

• Sagun Parakh,
• Sagun Parakh,
• Sagun Parakh,
• Tracy L. Leong,
• Tracy L. Leong,
• Tracy L. Leong,
• Tracy L. Leong,
• Sarah A. Best,
• Sarah A. Best,
• Ashleigh R. Poh,
• Ashleigh R. Poh

Affiliations

Sagun Parakh

Department of Medical Oncology, Austin Health, Heidelberg, VIC, Australia

Sagun Parakh

Tumor Targeting Laboratory, The Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia

Sagun Parakh

School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia

Tracy L. Leong

Department of Respiratory Medicine, Austin Health, Heidelberg, VIC, Australia

Tracy L. Leong

Faculty of Medicine, University of Melbourne, Parkville, VIC, Australia

Tracy L. Leong

Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia

Tracy L. Leong

Department of Medical Biology, University of Melbourne, Melbourne, Australia

Sarah A. Best

Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia

Sarah A. Best

Department of Medical Biology, University of Melbourne, Melbourne, Australia

Ashleigh R. Poh

School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia

Ashleigh R. Poh

Cancer and Inflammation Laboratory, The Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia